Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
MedAdvisor Limited ( (AU:AHE) ) just unveiled an announcement.
Adheris Health reported a sharp deterioration in its Q2 FY26 performance, with operating revenue falling 45.8% year-on-year to $13.7 million and gross profit more than halving to $6.5 million, as lower customer renewal rates, weaker US vaccination activity and smaller pharma deal sizes weighed on results and margins. Newly appointed CEO and managing director John Ciccio has moved quickly to stabilise the business through a material cost reduction program, changes to the executive team and efforts to win back former clients, while the group ended the quarter with $8.1 million in net cash, rising to a pro-forma $14.2 million after receiving a $6.1 million holdback from the sale of its ANZ operations. The company also launched a new technology platform in December designed to deliver programs more efficiently and at scale, with management now prioritising extraction of commercial and operational benefits, including faster digital product innovation, improved execution and deeper patient engagement through embedded AI, in an effort to restore growth and strengthen its competitive position with pharma customers.
The most recent analyst rating on (AU:AHE) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:AHE Stock Forecast page.
More about MedAdvisor Limited
Adheris Health Limited is an Australian-listed healthcare technology company focused on patient engagement solutions for the pharmaceutical and broader healthcare sectors. The business operates primarily in the US, delivering omnichannel adherence and communication programs for pharma clients, with a growing emphasis on digital platforms, data-driven personalization and AI-enabled tools to improve patient support and outcomes.
Average Trading Volume: 1,282,926
Technical Sentiment Signal: Sell
Current Market Cap: A$14.65M
For detailed information about AHE stock, go to TipRanks’ Stock Analysis page.